Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
- PMID: 19937477
- PMCID: PMC3135335
- DOI: 10.1007/s11605-009-1096-z
Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
Abstract
Background: Lymph node metastases are prognostically significant in pancreatic ductal adenocarcinoma. Little is known about the significance of direct lymph node invasion.
Aim: The aim of this study is to find out whether direct lymph node invasion has the same prognostic significance as regional nodal metastases.
Methods: Retrospective review of patients resected between 1/1/1993 and 7/31/2008. "Direct" was defined as tumor extension into adjacent nodes, and "regional" was defined as metastases to peripancreatic nodes.
Results: Overall, 517 patients underwent pancreatic resection for adenocarcinoma, of whom 89 had one positive node (direct 26, regional 63), and 79 had two positive nodes (direct 6, regional 68, both 5). Overall, survival of node-negative patients was improved compared to patients with positive nodes (N0 30.8 months vs. N1 16.4 months; p < 0.001). There was no survival difference for patients with direct vs. regional lymph node invasion (p = 0.67). Patients with one positive node had a better overall survival compared to patients with >/=2 positive nodes (22.3 and 15 months, respectively; p < 0.001). The lymph node ratio (+LN/total LN) was prognostically significant after Cox regression (p < 0.001).
Conclusions: Isolated direct invasion occurs in 20% of patients with one to two positive nodes. Node involvement by metastasis or by direct invasion are equally significant predictors of reduced survival. Both the number of positive nodes and the lymph node ratio are significant prognostic factors.
Figures





Similar articles
-
Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.Am J Surg Pathol. 2011 Feb;35(2):228-34. doi: 10.1097/PAS.0b013e318206c37a. Am J Surg Pathol. 2011. PMID: 21263243
-
Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.Eur J Surg Oncol. 2012 Apr;38(4):333-9. doi: 10.1016/j.ejso.2011.12.020. Epub 2012 Feb 7. Eur J Surg Oncol. 2012. PMID: 22317758
-
Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.J Surg Oncol. 2015 Sep;112(4):396-402. doi: 10.1002/jso.24011. Epub 2015 Aug 25. J Surg Oncol. 2015. PMID: 26303811 Clinical Trial.
-
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.World J Gastroenterol. 2016 Jul 28;22(28):6424-33. doi: 10.3748/wjg.v22.i28.6424. World J Gastroenterol. 2016. PMID: 27605878 Free PMC article. Review.
-
Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review.Ann Surg Oncol. 2024 Jul;31(7):4654-4664. doi: 10.1245/s10434-024-15213-z. Epub 2024 Apr 11. Ann Surg Oncol. 2024. PMID: 38602578 Free PMC article.
Cited by
-
Dramatic Survival Benefit Related to R0 Resection of Pancreatic Adenocarcinoma in Patients With Tumor ≤25 mm in Size and ≤1 Involved Lymph Nodes.Clin Transl Gastroenterol. 2013 Mar 21;4(3):e33. doi: 10.1038/ctg.2013.4. Clin Transl Gastroenterol. 2013. PMID: 23515131 Free PMC article.
-
Identification of an N staging system that predicts oncologic outcome in resected left-sided pancreatic cancer.Medicine (Baltimore). 2016 Jun;95(26):e4035. doi: 10.1097/MD.0000000000004035. Medicine (Baltimore). 2016. PMID: 27368029 Free PMC article.
-
Resected pancreatic adenocarcinoma: An Asian institution's experience.Cancer Rep (Hoboken). 2021 Oct;4(5):e1393. doi: 10.1002/cnr2.1393. Epub 2021 May 3. Cancer Rep (Hoboken). 2021. PMID: 33939335 Free PMC article.
-
Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients.Front Oncol. 2022 Oct 5;12:992906. doi: 10.3389/fonc.2022.992906. eCollection 2022. Front Oncol. 2022. PMID: 36276058 Free PMC article.
-
Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.World J Surg Oncol. 2016 Sep 20;14(1):248. doi: 10.1186/s12957-016-1005-3. World J Surg Oncol. 2016. PMID: 27644962 Free PMC article.
References
-
- American Cancer Society. www.cancer.org.
-
- Ferrone CR, Brennan MF, Gonen M, et al. Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg. 2008;12 (4):701–706. - PubMed
-
- Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10(9):1199–210. discussion 1210–1. - PubMed
-
- Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247(3):456–462. - PubMed
-
- Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198(5):722–731. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical